Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modified haemoglobins and perfluorocarbons.

K F Waschke1, T Frietsch

  • 1Department of Anaesthesiology and Critical Care Medicine, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany. km20@rumms.uni-mannheim.de

Current Opinion in Anaesthesiology
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert-based definition and criteria from the International HIT-OVER Forum.

Transfusion·2024
Same author

[Safety of cell salvage in tumor surgery : Systematic review with meta-analysis].

Der Anaesthesist·2020
Same author

[Dealing with massive bleeding and associated perioperative coagulopathy: recommendations for action of the German Society of Anaesthesiology and Intensive Care Medicine].

Der Anaesthesist·2013
Same author

[Epidural anesthesia in obstetrics: an accidentally placed intrathecal catheter--remove it or use it?].

Zeitschrift fur Geburtshilfe und Neonatologie·2011
Same author

[Artificial blood - coming soon or never reaching clinical maturity?].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

Blood viscosity modulates tissue perfusion: sometimes and somewhere.

Transfusion alternatives in transfusion medicine : TATM·2009

Artificial oxygen carriers, developed over decades, are nearing clinical use for severe hemorrhage. While not replacing blood transfusions, they offer rapid oxygen delivery, potentially expanding to other medical emergencies.

Area of Science:

  • Biomedical Engineering
  • Emergency Medicine
  • Hematology

Background:

  • Artificial oxygen carriers (AOCs) have undergone extensive research and development.
  • Key technologies include hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon emulsions (PFCs).
  • These advanced products are now in clinical investigation stages.

Purpose of the Study:

  • To review the current development stage of artificial oxygen carriers.
  • To discuss their potential impact on fluid resuscitation and trauma management.
  • To explore future therapeutic indications for AOCs.

Main Methods:

  • Review of decades of research and product improvements in HBOCs and PFCs.
  • Analysis of current clinical investigations involving AOCs.

Related Experiment Videos

  • Discussion of the physiological role and potential applications of AOCs.

    • Main Results:

    • Artificial oxygen carriers are at a critical stage of development, with various HBOCs and PFCs in clinical trials.
    • AOCs show potential to significantly alter hemorrhage management by bridging transfusion delays.
    • Further research is investigating their efficacy in compromised circulation and broader medical applications.

    Conclusions:

    • Artificial oxygen carriers will not replace human blood transfusions but will complement them in trauma care.
    • AOCs offer a vital solution for rapid tissue oxygenation during severe hemorrhage.
    • Potential for expanded use in emergency medicine, trauma anesthesia, and other specialties exists with safe and effective AOCs.